Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China flag China · Delayed Price · Currency is CNY
10.45
+0.34 (3.36%)
Sep 14, 2026, 3:04 PM CST

SHE:300434 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,0071,0071,0661,1711,2001,006
Other Revenue
30.1731.2336.0538.0942.7947.74
1,0371,0381,1021,2091,2431,054
Revenue Growth
-3.24%-5.80%-8.84%-2.69%17.95%35.53%
Cost of Revenue
417.65435.38473.18467.99480.74459.56
Gross Profit
619.65603.02629.17741.21761.87593.94
Selling, General & Admin
374.23391.93430.14429.02421.07419.15
Research & Development
55.1655.035050.0139.1837.45
Other Operating Expenses
25.4517.4520.122.4518.7417.64
Operating Expenses
455.63463.72500.79500.6481.06478.49
Operating Income
164.02139.29128.38240.61280.8115.45
Interest Expense
-1.11-1.16-1.32-0.67-0.46-0.02
Interest & Investment Income
2.783.165.3412.092.742.97
Currency Exchange Gain (Loss)
-2.82-0.920.610.421.38-0.18
Other Non Operating Income (Expenses)
-1.07-1.47-3.893.28-7.91-0.46
EBT Excluding Unusual Items
161.79138.89129.12255.73276.56117.77
Impairment of Goodwill
----67.51--23.17
Gain (Loss) on Sale of Investments
6.06-1.03-11.35-18.43-11.97-9.67
Gain (Loss) on Sale of Assets
0.390.17-0.020.2517.77-0
Asset Writedown
-0.02-0.35-4.87-0.78-1.4-2.72
Other Unusual Items
20.1315.099.787.769.5811.34
Pretax Income
188.36152.78122.66177.02290.5493.54
Income Tax Expense
29.3624.1534.156.3177.4927.43
Earnings From Continuing Operations
159128.6288.56120.71213.0566.1
Minority Interest in Earnings
2.3533.25.495.740.38
Net Income
161.35131.6291.76126.2218.7966.48
Net Income to Common
161.35131.6291.76126.2218.7966.48
Net Income Growth
36.39%43.44%-27.29%-42.32%229.10%-
Shares Outstanding (Basic)
399399399407405391
Shares Outstanding (Diluted)
399399399407405391
Shares Change
0.00%-0.03%-2.00%0.48%3.60%-2.75%
EPS (Basic)
0.400.330.230.310.540.17
EPS (Diluted)
0.400.330.230.310.540.17
EPS Growth
36.38%43.48%-25.81%-42.59%217.65%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
77.93108.3285.2385.04268.8951.03
Free Cash Flow Per Share
0.200.270.210.210.660.13
Dividend Per Share
0.0820.0820.0690.110--
Dividend Growth
18.84%18.84%-37.27%---
Gross Margin
59.74%58.07%57.07%61.30%61.31%56.38%
Operating Margin
15.81%13.41%11.65%19.90%22.60%10.96%
Profit Margin
15.55%12.68%8.32%10.44%17.61%6.31%
Free Cash Flow Margin
7.51%10.43%7.73%7.03%21.64%4.84%
EBITDA
257.69240.13231.35334.33371.87202.41
EBITDA Margin
24.84%23.13%20.99%27.65%29.93%19.21%
D&A For EBITDA
93.67100.83102.9793.7291.0686.96
EBIT
164.02139.29128.38240.61280.8115.45
EBIT Margin
15.81%13.41%11.65%19.90%22.60%10.96%
Effective Tax Rate
15.58%15.81%27.80%31.81%26.67%29.33%
Revenue as Reported
1,0371,0381,1021,2091,2431,054
Advertising Expenses
-49.9269.5774.9959.769.59